UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 22, 2024 4:00 P.M.
Form:
S-3
CIK:
0001408443
Company Name:
Milestone Pharmaceuticals Inc.
File Number:
333-283162